Not applicableUnknownNCT04320667What this trial is testingUrinary T Cell Biomarker for Prediction in ANCA GlomerulonephritisWho this might be right forGlomerulonephritis Acute Charite University, Berlin, Germany 79
Post-approval studies (Phase 4)UnknownNCT05969522What this trial is testingStratified Therapy on Pediatric AAGNWho this might be right forAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisANCA-Associated Glomerulonephritis Wang Mo 200
Testing effectiveness (Phase 2)Ended earlyNCT00424749What this trial is testingRituxan in Churg Strauss Syndrome With Renal InvolvementWho this might be right forChurg-Strauss Syndrome Fernando Fervenza 4
Not applicableLooking for participantsNCT07010250What this trial is testingEpithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisWho this might be right forANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more Assistance Publique - Hôpitaux de Paris 146
Testing effectiveness (Phase 2)Study completedNCT00001256What this trial is testingSteroids and Methotrexate to Treat Systemic VasculitisWho this might be right forInflammationVasculitisWegener's Granulomatosis National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT04428398What this trial is testingUrinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated GlomerulonephritisWho this might be right forGlomerulonephritis Acute Charite University, Berlin, Germany 100
Very early researchLooking for participantsNCT07203404What this trial is testingAnti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.Who this might be right forSLELNANCA Associated Vasculitis+6 more Nanjing Bioheng Biotech Co., Ltd. 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402What this trial is testingAn Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesWho this might be right forLupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more Alpine Immune Sciences, Inc. 72
Early research (Phase 1)Looking for participantsNCT06308978What this trial is testingFT819 in B-cell Mediated Autoimmune DiseaseWho this might be right forAntineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more Fate Therapeutics 244
Not applicableEnded earlyNCT02294344What this trial is testingThe Clinical Efficacy of DFPP in Patients With AAGNWho this might be right forAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Zhi-Hong Liu, M.D. 14
Early research (Phase 1)Looking for participantsNCT06285279What this trial is testingThe BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney DiseasesWho this might be right forLupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1 more Nanjing University School of Medicine 24
Early research (Phase 1)Active Not RecruitingNCT06294236What this trial is testingStudy Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Who this might be right forLupus ErythematosusSystemic Lupus ErythematosusSLE (Systemic Lupus)+3 more Sana Biotechnology 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292What this trial is testingMSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.Who this might be right forLupus Nephritis (LN)ANCA-Associated Glomerulonephritis Shanghai Changzheng Hospital 12
Not applicableStudy completedNCT05894317What this trial is testingVascular Access Complications for Therapeutic Apheresis in NephrologyWho this might be right forVascular Access ComplicationApheresis Related Complication Central Hospital, Nancy, France 60
Very early researchLooking for participantsNCT07507201What this trial is testingAllogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more The Children's Hospital of Zhejiang University School of Medicine 15
Early research (Phase 1)Looking for participantsNCT07305116What this trial is testingCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more The Children's Hospital of Zhejiang University School of Medicine 15
Testing effectiveness (Phase 2)Looking for participantsNCT06350110What this trial is testingFourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more Essen Biotech 75
Testing effectiveness (Phase 2)Looking for participantsNCT07746180What this trial is testingObinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated GlomerulonephritisWho this might be right forANCA-Associated Glomerulonephritis (AAGN)ANCA-Associated Vasculitis (AAV) Chinese PLA General Hospital 20
Very early researchNot Yet RecruitingNCT07389499What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney DiseasesWho this might be right forIgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more Grit Biotechnology 30
Early research (Phase 1)Looking for participantsNCT07104721What this trial is testingA Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesWho this might be right forSystemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18